Semiempirical analysis of 1.4-benzodiazepine alcoxy derivatives interactions with GABAa-receptor on the base of molecular docking data and pharmacological effect
DOI:
https://doi.org/10.11603/mcch.2410-681X.2017.v0.i4.8247Keywords:
molecular docking, alkoxy derivatives of 1.4-benzodiazepine, anticonvulsive action, analgesic action.Abstract
Introduction. Pharmacological spectrum of 1.4-benzodiazepine 3-alkoxy derivatives, in contrast to classical substances, has more prominent analgesic properties, but even among the synthesized and studied molecules there are compounds with different magnitude of this effect.
The aim of the study – to evaluate the molecular docking parameters of the theoretically generated structures of 1.4-benzodiazepine alkoxy derivatives with the GABA receptor complex and to compare these data with the pharmacological activity of the synthesized compounds.
The molecular docking procedure was carried out using the iGEMDOCK v2.1 program, optimized structures of already synthesized and theoretically designed molecules with differing substituents in the ortho position of the phenyl radical and the "7" position of the condensed system are generated in the Avogadro program (v 1.2.0). The average effective doses of compounds (penthylenetetrazole-induced seizures, 120 mg/kg, subcutaneously 30 min after compounds administration) were studied in white mice.
The binding energy of all the generated structures is within the ranges of 81.6–96.8 kcal/mol. Virtual docking data analysis of substituted alkoxy derivatives allows identifying several binding sites inherent for 7-chloro- or 7-bromo-substituted benzodiazepine derivatives. The greatest influence on the binding of chlorine-substituted alkoxy derivatives have regions with a high polarity amino acids (16-23 D) and similar hydrophilicity and hydrophobicity. The contribution of Van der Waals and hydrogen interactions to the total binding energy is determined by the presence of halogen (chlorine or bromine). In penthylenetetrazole-induced seizures test the compounds containing the chlorophenyl substituent in the hetero ring were most active (ED50 (0.42±0.10) μmol/kg for the propyloxy derivative and (0.51±0.17) μmol/kg for the ethyloxy derivative) while for the compounds with the phenyl radical, the ED50 value were much higher (5.1±2.7) μmol/kg and (17.75±1.93) μmol/kg, respectively). The analgesic effect is mainly due to the lkoxy derivatives possibility of binding to a center containing residues of basic amino acids.
References
Yu-Chen Chen, Totrov, M., & Abagyan, R. (2014). Docking to multiple pockets or ligand fields for screening, activity prediction and scaffold hopping. Future of Medicinal Chemistry, 6 (16), 1741-1755.
Kitchen, D.B., Decornez, H., Furr, J.R., & Bajorath, J. (2004). Docking and scoring in virtual screening for drug discovery: methods and applications. Nature Reviews Drug Discovery, 3, 935-949.
Pavlovsky, V.I., Tsymbalyuk, O.V., Martynyuk, V.S., Kabanova, T.A., Semenishyna, E.A., Khalimova, E.I., & Andronati, S.A. (2013). Analgesic effects of 3-substituted derivatives of 1.4-benzodiazepines and their possible mechanisms. Neurophysiology, 45(5/6): 427-432.
Golovenko, N.Ya., Larionov, V.B., Reder, A.S., Voloshchuk, N.I., Valivodz, I.P., & Taran, I.V. (2016). Aktivatsiya GAMK-ergicheskoy sistemy propiloksiproizvodnim z 1.4-benzdiazepina na modelyakh neyropaticheskoy boli i sudorog, indutsirovannykh korazolom [GABA-ergic system activation with 1.4-benzodiazepine propyloxyderivative onthe models of neuropathic pain and pentylenetetrazol-induced seizures]. Zhurnal Natsionalnoy Akademii meditsinskikh nauk Ukrainy – Journal of the National Academy of Medicinal Sciences of Ukraine, 3, 247-252.
Golovenko, M.Ya., Reder, A.S., Larionov, V.B., & Valivodz, I.P. (2017). The effect of propoxazepam on development of thiosemicarbazide-induced GABA-deficient seizures in mice. Klinichna Farmatsiia – Clinical Pharmacy, 21 (2), 34-40.
Golovenko, M.Ya., Larionov, V.B., Reder, A.S., & Valivodz, I.P. (2017). Efektornyy analiz vzaimodeystviya propoksazepama s antagonistami neyroretseptorov GAMK i glitsina [Effect analysis of propoxazepam interactions with GABA and glycine antagonists]. Neyrokhimiya – Neurochemistry, 34 (4), 1-8 [in Russian].
Yang, J.-M., & Chen, C.-C. (2004). "GEMDOCK: A generic evolutionary method for molecular docking". Proteins: Structure, Function and Bioinformatics, 55, 288-304.
Yang, J.-M., Chen, Y.-F., Shen, T.-W., Kristal, B.S., & Hsu, D.F. (2005). Consensus scoring criteria for improving enrichment in virtual screening. J Chem. Inf. Model, 45 (4), 1134-1146.
Medyk, V.A., Tokmachev, M.S., Fishman, B.B. (2000). Statistika v meditsine i biologii: rukovodstvo v 2 t. [Statistics in medicine and biology: guideline in 2 vol.]. Komarov, Yu.M. (Ed.) Мoscow: Meditsina [in Russian].
Lapach, S.N., Chubenko, A.V., & Babych, P.N. (2001). Statisticheskiye metody v medico-biologicheskikh issledovaniyakh s ispolzovaniyem Excel [Statistical methods in medical and biological studies using Excel]. Kyiv: Morion [in Russian].
Voronina, T.A., Golovenko, N.Ya., & Larionov, V.B. (2011). Rol 3-oksimetabolita fenazepamai levany v realizatsii ikh neyrotropnogo deystviya [The role of phenazepam and levan 3-oxymethabolite in their neurotrope action realization]. Farmakokinetika i farmakodinamika – Pharmacokinetics and Pharmacodynamics, 1, 44-49 [in Russian].
Holovenko, M.Ya., Larionov, V.B., Valivodz, I.P., Zhukova, N.O. (2015). Mekhanizmy reaktii metabolizmu etoksozepamu v homohenatak pechinky shchuriv [The metabolism reactions mechanisms of 3-ethoxozepam in rat liver homogenates]. Zaporizkyi medychnyi zhurnal – Zaporizhian Medical Journal, 4 (91), 100-104 [in Ukrainian].
Otto, M.W., Bruce, S.E., & Deckersbach, T. (2005). 1.4 Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need. J. Clin. Psychiatry, 66 (2), 34-38.
Stewart, S.A. (2005). The effects of benzodiazepines on cognition. J. Clin. Psychiatry, 66 (2), 9-13.
Griffin, C.E.3r1, Kaye, A.M., Bueno, F.R., & Kaye, A.D. (2013). Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J., 13 (2), 214-223.
Walters, R.J., Hadley, S.H., Morris, K.D.W., & Amin, J. (2000). Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms. Nature Neuroscience, 3, 1274-1281.
Smith, T.A. (2001). Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment. Br. J. Biomed. Sci., 58 (2), 111-121.
Sigel, M.E. (2012). Steinmann structure, function, and modulation of GABAA Receptors. J. Biol. Chem., 287 (48), 40224-40231.
